Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells

PaperCitations, authors & open-access status

Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 153 citations, 2016 year and hybrid oa status.

153
Citations
2016
Year
hybrid
OA Status

Related on ScholarIQ

Qiang Lu
Author
CAR-T cell therapy research
Topic
CAR-T cell therapy research
Topic
Virus-based gene therapy research
Topic
Silicon Carbide Semiconductor Technologies
Topic
470M+ articles · free account